Modified Capecitabine and Oxaliplatin (mCAPOX) for Patients With GI Malignancies

Summary

This study is a single arm, non-randomized feasibility study with tolerability and toxicity evaluation as primary endpoints which seeks to determine if a modified administration schedule of capecitabine with oxaliplatin will result in less toxicity than standard FOLFOX or CAPOX regimens.

Timeline

Start

2024-10-21

Primary completion

2026-11

Completion

2026-11

Drugs

Indications